📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

BRAF inhibitors and their immunological effects in malignant melanoma. (2022)

First Author: Adams R

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/1744666x.2022.2044796

PubMed Identifier: 35195495

Publication URI: http://europepmc.org/abstract/MED/35195495

Type: Journal Article/Review

Volume: 18

Parent Publication: Expert review of clinical immunology

Issue: 4

ISSN: 1744-666X